Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Plus Carboplatin With Radiation in Inoperable NSCLC
NCT00886678Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jul 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Tumor Response Rate. Status: unknown.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00886678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886678.